18:I[66739,["/_next/static/chunks/0u0nyy7wb9me2.js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i","/_next/static/chunks/05hx6kuf6-oy4.js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i","/_next/static/chunks/12hmyxte1w1dw.js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i","/_next/static/chunks/166.u_60qj09..js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i","/_next/static/chunks/0g9_wl34k-6l4.js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i","/_next/static/chunks/06dn~uer6.43l.js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i"],"default"] 1a:I[38632,["/_next/static/chunks/0qqtp3r0h7kah.js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i","/_next/static/chunks/0iukvycbd42rl.js?dpl=dpl_EVxQmm5ee6SfSwpTLEi7dkcqj48i"],"IconMark"] 19:T469,

In this episode of Denatured, you’ll listen to Christina Takke, managing partner at V-Bio Ventures and Mariette van der Velden-Roesink, founding partner at Curie Capital. We examine why Benelux delivers world‑class science yet remains an investment patchwork, and what it will take to knit the region into a truly unified biotech investment corridor.

Host

⁠Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Christina Takke, Managing Partner, V-Bio Ventures

Mariette van der Velden-Roesink, Founding Partner, Curie Capital

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Breaking borders: Building biotech scale in Benelux

BioSpace

Breaking borders: Building biotech scale in Benelux